Health AI Register Logo
ProductsPlatformsCompaniesNewsContact
ProductsMindpeak Lung (NSCLC) PD-L1 (SP263) RoIcha

Vendor source

Reviewed 21 Jul 2026

Completeness Strong (67%)

Mindpeak Lung (NSCLC) PD-L1 (SP263) RoIcha

Mindpeak GmbH

Mindpeak Lung (NSCLC) PD-L1 (SP263) RoI is software for automated analysis of digital histopathology images of non-small cell lung cancer (NSCLC) tissue samples. It supports the analysis of scanned, PD-L1 stained NSCLC samples by detecting and classifying IHC-stained tumor cells within predefined regions of interest (ROI). Tumor cells are classified as not-stained (negative) or stained (positive), with a tumor proportion score (TPS) provided as the ratio of positive tumor cells to all tumor cells. Pathologists must review, adjust, and validate results, and decide on the final diagnosis.

No papers to support — we monitor for new evidence.

Mindpeak Lung (NSCLC) PD-L1 (SP263) RoIcha
Mindpeak Lung (NSCLC) PD-L1 (SP263) RoIcha
Mindpeak Lung (NSCLC) PD-L1 (SP263) RoIcha
Mindpeak Lung (NSCLC) PD-L1 (SP263) RoIcha
Mindpeak Lung (NSCLC) PD-L1 (SP263) RoIcha thumbnail 1
Mindpeak Lung (NSCLC) PD-L1 (SP263) RoIcha thumbnail 2
Mindpeak Lung (NSCLC) PD-L1 (SP263) RoIcha thumbnail 3
Mindpeak Lung (NSCLC) PD-L1 (SP263) RoIcha thumbnail 4

Key Features

  • Cancer detection
  • Cell classification
  • Tissue segmentation
  • TPS score

General Information

Product name

Mindpeak Lung (NSCLC) PD-L1 (SP263) RoIcha

Modality

Histopathology

Main task

Scoring (IHC quantification)

Subspeciality

Pulmonary pathology

Organ/Specimen source

Not specified

Disease targeted

Lung cancer

Specimen type

Not specified

Staining

IHC

Stain subtype

PD-L1

Regulatory Information

CE-IVD Certification

Pathway:

In Vitro Diagnostic Directive (IVDD)

Class:

General IVD Devices

Verified by Health AI Register

Scanner Brands Certified for Use (CE-IVD)

Roche, Phillips, 3DHistech, Hamamatsu, Leica

Scanner Models Certified for Use (CE-IVD)

Not specified

Other certifications

Not specified

Evidence & Research

No research papers or evidence on file yet.

The registry monitors publications for new evidence.

Technical Specifications

Patient population age

Not specified

Input

whole slide image, primary breast cancer tissue, 0.5µm/pixel ± 0.05 µm/pixel resolution, 20x scan magnification

Input format

BIF, MRXS, NDPI, Others, SVS, TIFF

Output

Cell classification, Image Annotations, Clinical Score, Cell Count

Output format

JSON

Integration

Integration via AI marketplace or distribution platform, Integration with hospital reporting system, Integration with IMS (Image Management System), Integration with LMS (Laboratory Management System)

Deployment

Cloud-based, Locally on dedicated hardware, Locally virtualized (virtual machine, docker)

Trigger for analysis

Automatically, right after the image acquisition

Processing time

1 - 10 minutes

Population

Mindpeak Lung (NSCLC) PD-L1 (SP263) RoI is not intended for non-cancer lung tissue, necrotic tissue, other subtypes of non-small cell lung cancer, tissue acquired by resection, cytology specimens from fine needle aspiration, tissue stained with IHC assays other than VENTANA PD-L1 (SP263).

Viewer systems

Digital Lab (Smart in Media), EMPAIA, FullFocus (Paige), Pathflow (Gestalt), PathPresenter, Proscia, Sectra, Telemis, Tribun

Market Presence

On market since

May 2022

AI Platforms

Gestalt, Paige, PathPresenter, Proscia, Roche Navify, Sectra Amplifier Store, Smart in Media, Telemis, Tribun Health

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

One-time license fee, Pay-per-use, Subscription

Based on

Number of analyses

Source: Vendor | First published: Jul 30, 2025 | Last updated: Jul 21, 2026